<SUBMISSION>
<ACCESSION-NUMBER>0001140361-07-008548
<TYPE>424B3
<PUBLIC-DOCUMENT-COUNT>2
<FILING-DATE>20070427
<DATE-OF-FILING-DATE-CHANGE>20070427
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>BIOSANTE PHARMACEUTICALS INC
<CIK>0001023024
<ASSIGNED-SIC>2836
<IRS-NUMBER>582301143
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>424B3
<ACT>33
<FILE-NUMBER>333-116110
<FILM-NUMBER>07796486
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>111 BARCLAY BLVD STE 280
<CITY>LINCOLNSHIRE
<STATE>IL
<ZIP>60069
<PHONE>8474780500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>111 BARCLAY BLVD STE 280
<CITY>LINCOLNSHIRE
<STATE>IL
<ZIP>60069
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>BEN ABRAHAM TECHNOLOGIES INC
<DATE-CHANGED>19991027
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>prospectussupp2.htm
<DESCRIPTION>424(B)(3) SUPPLEMENT 2
<TEXT>
<html>
  <head>
    <title>
      424(b)(3) Supplement 2
</title>
<!-- Licensed to: EDGARfilings, Ltd-->
<!-- Document Created using EDGARizer HTML 3.0.4.0 -->
<!-- Copyright 2006 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>
  <body bgcolor="#ffffff"><br>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PROSPECTUS
                SUPPLEMENT NO. 2</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>(to
                Prospectus Dated June 25, 2004)</strong></font></div>
            </td>
            <td align="right" valign="top" width="40%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Filed
                Pursuant to Rule 424(b)(3)</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>File
                No. </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>333-116110</strong></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><img src="biosantelogo6.jpg" alt=""></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>3,483,996
      Shares</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>Common
      Stock</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>___________________</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Prospectus Supplement No. 2 supplements the prospectus dated June 25, 2004
      and
      Prospectus Supplement No. 1 dated October 26, 2004, relating to the 3,483,996
      shares of common stock of BioSante Pharmaceuticals, Inc. that may be offered
      for
      sale for the account of several stockholders of BioSante, their respective
      donees or pledgees, as stated under the heading &#8220;Plan of Distribution&#8221; in the
      original prospectus. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Prospectus Supplement No. 2 is being filed to update the original table of
      Selling Stockholders in the original prospectus, as supplemented, with respect
      to a change in beneficial ownership that has occurred since the date of the
      original prospectus, as supplemented. This Prospectus Supplement No. 2 is not
      complete without, and may not be delivered or utilized except in connection
      with, the original prospectus, as supplemented. This Prospectus Supplement
      No. 2
      is qualified by reference to the original prospectus, as supplemented, except
      to
      the extent that the information contained in this Prospectus Supplement No.
      2
      supersedes the information contained in the original prospectus, as
      supplemented.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>The
      common stock offered involves a high degree of risk. We refer you to &#8220;Risk
      Factors,&#8221; beginning on page 8 of the original prospectus.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
      the Securities and Exchange Commission nor any state securities commission
      has
      approved or disapproved of these securities or determined if this Prospectus
      Supplement No. 2 is truthful or complete. Any representation to the contrary
      is
      a criminal offense. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">___________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      date
      of this Prospectus Supplement No. 2 is April 27, 2007</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SELLING
      STOCKHOLDERS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      table
      of selling stockholders in the original prospectus lists ProMed Partners, L.P.,
      ProMed Partners II, L.P., ProMed Offshore Fund, Ltd. and Paul Scharfer as
      beneficially owning shares issuable upon exercise of warrants of which could
      be
      offered for sale by these stockholders pursuant to the original prospectus,
      as
      supplemented. In April 2007, each of ProMed Partners, L.P., ProMed Partners
      II,
      L.P., ProMed Offshore Fund, Ltd. and Paul Scharfer, respectively, transferred
      warrants to purchase 12,030, 2,895, 1,950 and 5,625, respectively, of BioSante
      common stock to Crestview Capital Master, LLC. The table of selling stockholders
      as it relates to the shares of BioSante common stock listed as held by ProMed
      Partners, L.P., ProMed Partners II, L.P., ProMed Offshore Fund, Ltd. and Paul
      Scharfer in the original prospectus, as supplemented, is hereby updated through
      April 27, 2007 and amended to reflect the foregoing as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" id="ftable" width="100%">

          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: #ffffff solid;">&#160;</td>
            <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="8" valign="bottom" width="32%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shares
                Beneficially</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Owned
                Prior to the Offering</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="5" valign="bottom" width="21%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shares
                Beneficially</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Owned
                After</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Completion
                of</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>the
                Offering</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Selling
                Stockholder</strong></font></div>
            </td>
            <td width="2%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shares
                Subject to Options, Warrants, and Class C Special
                Stock</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Total
                Shares Beneficially Owned</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Percentage</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Number
                of</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shares</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Being</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Offered</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Number</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
            <td colspan="2" valign="bottom" width="10%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Percentage</strong></font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: #ffffff thin solid;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ProMed
                Partners, L.P. (1)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ProMed
                Partners II, L.P. (1)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ProMed
                Offshore Fund, Ltd. (1)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Paul
                Scharfer (2)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">37,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">37,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">0</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">--</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="bottom" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Crestview
                Capital Master, LLC (3)</font></div>
            </td>
            <td width="2%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">197,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">197,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">22,500</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">175,000</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="right" valign="bottom" width="9%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 0px; TEXT-INDENT: 0px; MARGIN-RIGHT: 0px; FONT-FAMILY: Times New Roman">*</font></div>
            </td>
            <td align="left" valign="bottom" width="1%" style="border-bottom: medium none;">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">__________________________________</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Less
      than
      one percent (1%)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">David
      Musket and Barry Kurokawa, as the two investment managers of ProMed Offshore
      Fund, Ltd., ProMed Partners II, L.P. and ProMed Partners, L.P. have investment
      and voting power over the shares of BioSante common stock held by ProMed
      Offshore Fund, Ltd. ProMed Partners II, L.P. and ProMed Partners, L.P. David
      Musket is an affiliate of Musket Research Associates, Inc., a registered
      broker-dealer. Each of ProMed Offshore Fund, Ltd., ProMed Partners II, L.P
      and
      ProMed Partners, L.P. has represented to us that it purchased the shares being
      offered under this prospectus in the ordinary course of business, and at the
      time of purchase, had no agreements or understandings to distribute the
      shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Paul
      Scharfer is a registered representative of Musket Research Associates, Inc.,
      a
      registered broker-dealer. Paul Scharfer has represented to us that he purchased
      the shares being offered under this prospectus in the ordinary course of
      business, and at the time of purchase, had no agreement or understanding to
      distribute the shares.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Crestview
      Capital Partners, LLC is the sole manager for Crestview Capital Master, LLC.
      The
      power to vote or dispose of the shares beneficially owned by Crestview Capital
      Master, LLC is shared by Stewart Flink, Robert Hoyt and Daniel Warsh, each
      of
      whom disclaim beneficial ownership of the shares beneficially owned by Crestview
      Capital Master, LLC. Stewart Flink, a manager of Crestview Capital Partners,
      LLC, is the controlling shareholder of Dillon Capital Inc., a registered
      broker-dealer. Crestview Capital Master, LLC has represented to us that it
      purchased the shares being offered under this prospectus in the ordinary course
      of business, and at the time of purchase, had no agreements or understandings
      to
      distribute the shares.</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
  </body>
</html>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>biosantelogo6.jpg
<DESCRIPTION>LOGO
<TEXT>
begin 644 biosantelogo6.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!P17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@#`P#$!`@`9````3@``````
M``!@`````0```&`````!````141'05)I>F5R(%-O9G1W87)E(%-U:71E`'W_
MVP!#``8$!`4$!`8%!04&!@8'"0X)"0@("1(-#0H.%1(6%A42%!07&B$<%Q@?
M&104'2<='R(C)24E%API+"@D*R$D)23_VP!#`08&!@D("1$)"1$D&!08)"0D
M)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D)"0D
M)"3_P``1"`"/`5$#`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"
M`P0%!@<("0H+_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A
M!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9
MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H
MZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+
M_\0`M1$``@$"!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1
MH;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W
M^/GZ_]H`#`,!``(1`Q$`/P#QW_A8_C/_`*&C5_\`P*?_`!H/Q(\9#_F9]8_\
M"G_QKFJ&^[7Z$\/2M\*%<]NTGP)\;-;TZUU&SUK4&M[F)9HW.H'H>1D9]*L_
M\*O^/'_07OO_``8G_&OHOX6'/P[\.GJ?[/AY_P"`BM'6/&.@>'Y%BU;6+&PD
M<95;B94+?3-?(SS"I[1QC!:>11\Q_P#"KOCQ_P!!:_\`_!D?\::_PS^/D8.-
M1U.7Z:EC^M?1_P#PM#P5_P!#3HW_`(%I_C5G3O'7AG6)1!IVOZ9<R$XVPW"L
MWY9IO,*RW@O_``$SLCX]\0Q?%_PFC-K-YXC@1>LHN&9%^K`X_6N8_P"%D>,_
M^AGU?_P*?_&OT!NK&VO;9X+B&.6*089'7(-?$_QX^'<'P_\`&#+9*$T^_4SP
MQD\+_>4?ICZUZ&7X^GB'[.I!)E6-7PQX5^,GC#28=6TK6]0FM)B<.;\@\>VZ
ML_QK#\4_A\EN^O:_JD/VHD1[;UFZ?0U[?\`O%^@:7\-+"VO]:L+69&?,<DRJ
MPR>.IKA_VJO$.CZ]!HBZ;J=I>B-W+>1('VC'7@U%"O4GBO9."MZ!8\;_`.%D
M^,O^AGU?_P`"G_QH_P"%C^,_^AHU?_P*?_&N:HKZ'ZM2_E07.E_X6/XS_P"A
MHU?_`,"G_P`:/^%C^,_^AGU?_P`"G_QKFJ*/J]+^5!<Z3_A9'C+_`*&?5_\`
MP*?_`!I?^%D^,?\`H:=7_P#`I_\`&N:^M=?\*/!+>/\`QK8Z1)G[.#YD^./D
M'6HK4Z%*#G**T"YI>'M0^*OBV39HNI>(KPD\ND[[!_P(G%=G#\-/CS(NYM1U
M.//\+ZES^AKZFT;0;#P]I\6GZ=;1VT$2[0JC'X^YJOJ_B_0=!(74M9L+-C_S
MWG52?SKY6IFDI3_=4U;T"Q\R?\*O^/'_`$%K_P#\&1_QI/\`A5_QX_Z"U]_X
M,C_C7T=_PM'P5_T-6C?^!:_XT?\`"T/!7_0U:-_X%I_C2^OU_P#GVON%9'SB
M?AA\=U!+:M?X`R?^)D?\:\TO_'GCC3[V:SN/$FK)+"Y1T%V_!'H<U]JW'Q/\
M%-;RA?%.CDE"`!=+Z?6OA7Q1-'=^)-3EA9)8WN7977D$9Z@UZ>55)8B;C5@O
MN'8O_P#"R/&>/^1GU?\`\"G_`,:/^%C^,_\`H:-7_P#`I_\`&N:HKV_JU+^5
M!<Z7_A8_C/\`Z&C5_P#P*?\`QH_X6/XS_P"AHU?_`,"G_P`:YJBCZM2_E07.
ME_X6/XS_`.AHU?\`\"G_`,:/^%C^,_\`H:-7_P#`I_\`&N:HH^K4OY4%SI?^
M%C^,_P#H:-7_`/`I_P#&C_A8_C/_`*&C5_\`P*?_`!KFJ*/JU+^5!<Z7_A8_
MC/\`Z&C5_P#P*?\`QH_X6/XS_P"AGUC_`,"G_P`:YJBCZM2_E07.F3XD>,BX
M'_"3ZO\`C=/U_.O4+;X:_'*[MX[B'6+]HY%#J?[0(R",CO7A<?\`K%^HK]&_
M#P']@Z=Q_P`N\?\`Z"*\7-JRPS4:<5KY"@?#GB/Q+\0/">KW&D:GXDU6.\@(
M#A;UB*RC\1_&?_0SZO\`^!3_`.-;_P`?N/BKK7;]X/Y5YW7J86C3J48U'%7&
M=+_PL?QG_P!#1J__`(%/_C1_PL?QG_T-&K_^!3_XUS5%;?5J7\J"YTO_``L?
MQG_T-&K_`/@4_P#C1_PL?QG_`-#1J_\`X%/_`(US5%'U>E_*@N=+_P`+'\9_
M]#1J_P#X%/\`XU=T7XB^,)=8L8W\2ZNR-.@93<M@C(]ZXVM#0?\`D.:?_P!?
M$?\`Z$*BMAZ2@[107/O3SY_^?B7_`+ZHJ*BOB2SX`H;[M%#?=K[Y[$'Z!_"S
M_DG?AW_L'P_^@"OGO]K\#_A)]$_Z]G/ZU]!_"O\`Y)UX>_[!\/\`Z"*Q_B)\
M&-!^)=]:WFL3WD3VR%$%NX'!]<BOAL-7C0Q3J3V0SX6V#T%36ES<65Q'/;2/
M%-&P*,AP<^QKZZ_X9,\#?\_>K?\`?Y?\*N:-^S%X%T;4$O,7UX8CN$4\@*`_
M0#FO=K9YAI1T3^X5CT3P?<W-]X4TFYN]QN);2)Y,\%F*`GZ<U\\_M@2QF]\/
MP84SA)&^BY%?1&O^(-,\'Z+)?ZA,MO:6Z]<?D,"OA[XJ^/9_B)XKGU9E9+9%
M,5M&>T?8_4UY>4474Q"J+9$S/3/A?^SKH_CKP;::]<ZI>033LV5C`(X..E<S
M\<?A!8?"Y--:PO;BY^V%U/FCIQ7T'^S>!_PJO3!@???^=>??MA`+#X?./^6C
M_P`JZ,/C*TL=[-RTO:Q1\S!2S!5!))P`*]F^'G[->M^+8(M1U>;^RK*3!12,
MR2#UQV_&H_V;OAW!XM\5OJFHP![+3,-L89#R'[N?YU];:[K-AX8TB?4[UUAM
M;:,L3].PKIS/,YTY^PH;]Q6/(8/V2_!448\V]U:5^[>8H_3%8'B7]DFS:&23
MP_JTZ2C[L-V`RO\`B.E9&L_M;:O)J#G1]'MA:(V%\\DNX]>.!7J?PA^-=E\2
MU>RG@^PZI"-[0[LK(/537GS_`+0HQ]M-Z!H?(/BKPIJO@O5'TS6+-X)U/RY'
M##U4]Q7L'[(]K%+XNU29\%X[;Y<CIDU[/\<?AW:^.?!]R5@']H6:--!)CYN.
MJ_C7SK^SMXL@\*?$5(+YUBAO5,#%N`KYXS7H?77C,%-/=!8^Q?$=W+8:#J%U
M`,RPP.Z#W`K\\=6U2]UG4KF]OIY)IY'9F+G)'/3FOT:E1+F)D<!T=<%>H(->
M-:[^R[X0UG49KN"XO;)I6+/'&P*Y/ID<5Y65XREAI-5.I1\=X'H*,+Z"OK/_
M`(9#\-?]!C4?_'?\*;-^R'X;9#MUK4%/KA:]W^V\+W8'R=L'H/RI<=A^`KW/
MQO\`LNZUX>LI;W0[Q=5CC&YHV79(!_(UX;+"]O*\4BLKHVUE88VGN#7?AL72
MQ'\%B/?OA=^SKH_CWP98Z[<ZI=V\UQG<J*".#77?\,@^'_\`H.7W_?(KRWP'
M^T3K'@+PU;Z'9Z5:7$4&[#NY&>:Z/_AKSQ%_T`M/!]?,->)6I9DYOD>@'6-^
MR%X?"G&N7^?]T5R7BS]E#5=-M9;C0-434-@W&&9"C,/8^M6;/]K[5DG7[;X>
MMFB/!V2D-CVR*^AO!OBJR\;^'[76[$-Y4ZY"MU4]Q7'4Q&.PKYJKT&?GU=V=
MQI]U+:7<+PSQ$JZ,N&4CUKT;X)_"NR^)^I7]I?WD]JMK&KJ8@#G)]ZZS]J_P
MQ!IGB:PUFVA"?;8MLV.A8'_"K?['_P#R'=;.,GR$_F:]BOC93P2K0T8K'5?\
M,@>'?^@[J'Y+36_9`\/!6QKE^3VX6O5OB3XU;P%X5N=<2U%VUN5'EEMN[/O7
MAJ_MC7)X/A.+'K]J_P#L:\2A5Q]:+E3;=AAK7[(<L-N\VCZ^LLH&1%<Q8!]L
M@UX-XF\+ZEX0U.32]6M'M[J/DANCCU7VK[?^%WQ*LOB;H;ZE:P/;M$YCEA<@
M[6KRO]K;P_#)H^F:[%&JSQ2F!VZ94BNK!9C7C65&MJ*QB?#G]F[1O&'@[3M=
MN-4NHIKI!(451@&OINPM5LK&&V#,1#&J`GJ0!BOC;P=^T5XG\(Z%9Z+9V-@]
MK:J%5G4Y(^N:^Q-)NVN]-M;J10K2Q+(<=,D`G%<.:0KQFW6^00/*_&W[-VC>
M-?$=YKESJMW!-=$$J@&%_.O!_C;\*=/^%]UIL%A>7%T+I&=C)C(P:])^)O[1
M7B;P=XTU+1;&QL)(+9PJM*K$],]C7COC_P")FM?%:[T]=3M;:.>%O*B6!2"Q
M8\=37IY?#&049R?[L9E^"?`6N^/M3%CHMGYVWF23HD?U;^E>X:1^R'NB5M5U
M_:YY9+>'A3[,3S^5>Q_"OP/:^!/"5GI\,0^TM&);B0#YGD/)YKB_BM^T-;>`
M-9?1-/T[^T+V%0TI9MJ1Y[?6N>KF.)Q%;V>'`R5_9#\/`<ZYJ!;UV@5A>-_V
M8M#\+>%-3UJ#5[N62R@:55=1M.*S_P#AK[7GY_L"S4?]=&_PK+\4?M.:OXK\
M/W^B3:+:PI>Q&$NLARN?PK6G2S'G7,R=#Q0*#EB>P/IS5_0/^0YI_P#U\1_^
MA"J/.WD8SCWXQ_\`6J]H(_XGFG_]?$?_`*$*^DJ?PG<9]W4445\*:'P#0WW:
M*&^[7WCV,S]`_A7_`,D[\/?]@^'_`-!%<G\6_C;!\+=3LK&33)+XW49D!5PN
MW!YKK/A7_P`DZ\/?]@^'_P!!%?/_`.UM9W%QXHT=H()95%JX+(I..>^!7PV%
MHTZN+Y*FPS;_`.&P[;_H6Y/^_P"*NZ/^UMH][?QV^H:+<VL,A`\U'#!?J*^7
M1IM[D?Z+<?\`?HU=L/#&LZO?1V=GI]U+/,X4!8VY_,<5]#6RO!QA?]17/T%F
MBTWQ%I&)HH[RSNHP0K`,K*W3K7QI\>/AQ;_#WQ4%L5VZ=?(9H5).8R/O+^HQ
M]:^P?!NF3:-X6TK3KC`FM[6..09S\P4`_K7@?[84L(&@1-Q,?-;_`(",?UQ7
MB954E#%*$=F,]&_9OX^%>F?[S_SKS[]L7_4^'O\`??\`E7H/[.'_`"2O3/\`
M>?\`G7GW[8G^J\/?[[_RJ\-_R,?F(W_V3K"&W\#7EVO^LGNB&/T''\ZF_:KU
M&>T^'T-M&2J75TJ.1Z#G%8W[(NO13:)JNC,X\V&83(G?:>I_.NU_:$\(7/BO
MX>W$=G%YES:,+A%'\0'4#WQ4U/<Q]Y]P/B3&.AKO/@=J$VG_`!-T,Q.<2S"-
ML<<&N&E1H9"C*58'!!&"&]"#7K7[-_@N[U[QU::KY+"RTYC(TA'RLW85]+CI
MP6'DY,+'V7<HKVTJGD,A'Z5^=_BB,V'BW4XX6*>5>2!2.H.XFOT%UO48=)TB
M[O;APL4,3.Q)QT%?GAJ]P^L:W>72@R-<3O*B@'+9;@<=\5X600?--O8F9ZSX
M)_:8\3^&;6.SU*&/5K:(;5,C;)`/3/>NZB_;`T[:/.\.W()[*X-?-']GW_\`
MSXW''_3,\4?V??YYL;C_`+]FO6J97@YOF:_$H^G?^&P-(_Z%Z\_[^+6QX4_:
MC\-Z_J4.GW=A=Z>TS!$D<ADR3ZBODH:;?_\`/C<?]^S6_P"#/!.N^)-?LK6Q
MTVY8B96=S&P"`'J3@5SU\KPD8<R?XA<^_P`,CID;6##\\U\0?M`>'(O#GQ,O
MU@58X+H"X5,<`GK^M?;5G#]FM8(6&62-4)]2!7R-^TI+#J'Q8MK964B-(HY1
M]6%>/E$W"N^4;)_A1^SE+XPTZ+6->N7LK&;YHH8^)'7UYZ"O7K7]F#P!`@5[
M:[N#ZO+_`(5Z9HEE!9Z/9V\2A4CA10`,#@"OFSXT?'3Q?H/C2^T31[A+&WLR
M%#!`6<XZ\U:Q&*QE;EISL!Z@/V:/AXIS_9LP_P"VQKNO"GA+2_!FDII6D1/%
M:IR%9B>OUKXT_P"&A_B,?^8\?^_2_P"%?3?P&\5:KXQ\#Q:IJUR;BZ>5E+$8
M&`?05.883%4H7KRNO4#SO]K\?\2_0^/^6C?RK&_8_P#^0[K?_7!/YFMK]K[_
M`)!^A_\`71ZQ?V/?^0]K?_7!/YFNN'_(L8CUG]HX?\6KU+@?>3^=?$(X%?;_
M`.T;_P`DLU+_`'D_G7Q`>E=?#_\`!D3(^I/V/LG1==S_`,_*?^@BM[]J]1_P
MK>(X'%XG]:P?V/?^0-KO_7RG_H(K>_:O_P"2;Q?]?B?UKSZW_(R^970^/E!\
MQ>,<BOT;\/`?V%IW_7M'_P"@BOSD4X<'W'6OT;\.\^']./'-M'_Z"*Z.(OL$
MP/B;X_@'XJZR/^F@_E7/?#RV6Z\<Z!%)T:^AS^#`UUG[1>FS:?\`%'4I)D94
MG"2QL1PX([?2N&\*7ZZ1XFTK4';:EO=Q.Q]@PS^E>IAY*6#Y8]BC]%5`5``,
M`#BO-_$7P"\&>*-8N=4U&VN7N;IM[L)2!GZ5Z%:W*75K%<QL#'*@8>X(KYH^
M+WQD\?\`@3QM?Z;;R1168*M;%XLAE(SD'OZ5\G@Z=6=5QI.S&>BC]F'P`!C[
M)=8_Z[&N;^(?[/G@GPYX*U;5K*VN%N;6W:5"9">17E/_``T]\0_^?RT_[\BJ
M&N?M!>-_$>E7.DWUS;/;72&)U6+!P:]FG@\:I)RG^(CS;D``DCO^?.*OZ!_R
M'-/_`.OF/_T(50&2OMTQ].]7_#__`"&]/_Z^8_\`T(5]%47[IDH^[Z***^%-
MCX!H;[M%*>!7WKV,S]`?A61_PKOP]_V#X?\`T$5T5Q86=VP:XMH96'`+H#BO
MCS0?%OB:WT2RBM?$&H0Q+$@CC1AM4>GTJ_\`\)KXK_Z&74?^_@_PKX^IE53V
MC=R?:(^L/[&TW_GQM?\`OV/\*DAT^SM<M!;0Q$\DH@%?)7_":^+/^AEU+_OX
M/\*8_C+Q1(-A\2:H1Z^8!_2I_LJJ_M![1'U5K?B+2O#EE)>:E>P6L,8W%I&`
M_P#UU\4?&GXC'XC^+'NX-PT^V4Q6P/5E[L?3/]*3Q%I6JZWOEGU>\NW'\-Q(
M6'X`UPD\#VD[Q2*5D7J#7KY;ED:$O:-W8<US[8_9O`_X57IG^^_\Z\^_;$QY
M'A_O^\?^5>:^"_$_B'3M`@@LM<O[6W!.V.-@%'YUD?$C6]6U@68U/4KF]V9V
MF9@=OY5A0R^<<9[6^E[CY];%'X<>.KSX>>)[?6;3YHONSQ9QYD9ZCZU]M>#_
M`!UH?CO38[O3+N*4,N7B8_,A]"*_/O:9F"(I8YZ"NT\+:7JFCRK?6VHW5C-_
M=A8J<>AQUKJS++H5O?3LR>:Q]?:O\'?!&NWK7M]X?MGG8Y+KE<GU.*Z+3-&T
M;PII_P!FL+:WL+6,9(0!1]2>]?-]I\5O&%G`L*ZO+*<8W.`2*YKQ7XA\1^+(
MRE_KU]M/_+-6VK^(%>.LLK3]V<M!^T1U_P"T%\:;;4+23PKX?N/-1CBZN8VR
MI_V`?ZUY+\&HDF^)>@1R*KI]HY5AD?E7+ZII=UID^RX4A3]UAT-3^%[JXLM>
MM;BVGD@G1_ED3^$_XU]!2P<:.&]G3#F/T.&D:=C_`(\K;_OV*7^R=._Y\K;_
M`+]BODP^-?%F?^1EU+_OX/\`"C_A-?%G_0RZE_W\'^%?._V96_F#G1]9_P!D
MZ=_SY6O_`'[%2Q6UM;+^YBBC'^RH%?(Q\:^*\_\`(RZC_P!_!_A5>\\4^*+R
M-HY/$NJ!3W$F/Y4?V35?V@YT?3'CCXC:!X%TR:[U"]B\U5)CA#9=V],5\.>*
M/%%UXF\4W/B"X#"6>7S5!/0`_**T-?\`#VH7+/>/>W%ZYY)F<LV/;-<HRXP"
MIRIP=U>WEV6TZ*NW=BOS'W?\*OB%IOCGPO9307""[2)4GAW?,K`8S6AX@^&G
MA+Q5="ZUC1;:ZN.AD(P3]2*^*_"6F:G9,FH6^H75BS?=\ERI->@1>,/%**`O
MB34QC@'S`:\RME+C4;HR'[1(^@?^%%?#L<_\(U:_FU=3X<\-Z5X6TY+#2+-+
M2V4DB-#D`_C7RQ_PFGBP_P#,S:E_W\'^%)_PFGBP?\S+J(`_Z:#_``K">5UY
M+WIA[1'8_M?'_B7Z'_UT>L;]C[_D.ZU_UP3^9KS/XC:YJ^KQ6JZEJ=Y?*K';
MYYSCZ8JM\-]7U72+R[.G:A<63L@W&!@"1Z'->K'`R6"]C?<F^MSZM_:,P?A7
MJ0]T_G7Q"1\M>I^-/%?B+4?#\\%_K%[<0$@&*1AS]<5Y;CD9Z9KHRG"2H0<9
M/<J]SZA_8\/_`!)M=_Z^4_\`0!6_^U=@_#F+_K\3^M?/7PVUW6-*M[N/2]4N
M+%9'#$0L!GZYJ[\0?$6N:GHP@U'5;N\A,NY4F;C/X5Q5,NF\9[:XO:):'F_<
M#W_+WK[<^!_Q'L?&/A&QMGN(UU*T0130LV"=O&17Q$00,C'N*Z?PEIFH)*-1
MM[VXL3G*M"Y5C^(KOS/`QQ%-7>H^:Q]Q^)O`WASQ>J_VWI5O>%.%9QR/Q%?,
M?[2?@7P_X+OM(BT'3X[(3(Q<*20>?>FQ>,/%,2A1XEU,*!@'>,?B2*XCXC:U
MJ6K3V3:IJ5U>E58(93G%>9@<!5IU4^;1!SH]S^`GQQL+O38?#7B*[6"]MQM@
MN)#A9E^OJ*]GU3PYH'BJ%&U&QLK]"/E9U#D#KP:^`-&T2YU1]T/"J<%^PKT?
M1+S7]"B$5MXCU1%`^ZLIP/H#FKQ>41]ISTIV8>T2/J$_!OP)W\.61)]%Q7+?
M$[X6>#M)\!:W?6>A6D,\-LSQR*.5->0#QMXL(Q_PDFI`#UD'/Z5F>)/%WB6Z
MT2]AN=?OIXGC(>-V!5A^5<U++\1&:;F'.CR0G*CCGO\`G5[0/^0YI_\`U\1_
M^A"J`)"]R"![8J_H'_(<L./^7B/_`-"%?45%^Z?H%S[NHHHKX4V/@&AJ*&K[
MUF1Z5I'_`""K,X_Y9+5+7?$,FCSQQ"W1U9=V2:NZ1_R"K3_KDM<YXTADEO8&
MC1V&S^%<UPPC&4]3FC\0O_";3?\`/FGYU)!XYW.JS6@"_P"R:YC[-/\`\\)?
M^^#4D.GW5PR1I!*-W^S71[.F:<B/2H766,2#YE==P([5R7C6V2.[AN$`W2#!
M]ZZJQADMK&"%R"\:;>*Y3QM.CSV\*,-R<M6%+XM"(?$;?AC_`)`T)'O65X[Y
M%OGGFM7PQ_R!H?QK*\=?<M_K5TOXI7VBMX1TR.XNY+EURD0XXXW5U]_?1:;:
MR7$AP$'`K$\&Q[=+=NY;FCQG(ZZ:J@<2.!14]ZI8;U=C%N/%NH2RL\;HB9X&
M,XK:\/>)'U.4VUT`)!R".AKB<=>*T-#E:/5[9T_OX-:SHQ4;E3@N4[?7+!-2
MT^:,_?494^E<#8W)LKM963)1LD?I7IS*"C#'45Y??QB.]F"G_EH:6&9,#H3X
MWD_Y]1^=!\;OG_CU'YUS"QNYPJ[ZE%G<E<_9Y2/4(:KV4!V1T1\;/S_HH_.K
M=CXTCN)UCGMV3/`8'I7)-970_P"7:7_OD_X5:T[2+ZZN8U$,BKD$DKC%9NG$
MGD1Z-M!8Y.Y2,Y%<#X@LUMM9,2X"NP//UKOE0HJ+D'"A:X?QC+C6,I]Y%&:S
MH?$.&]CMH$5(41<`(!Q^%<GK?B2^LK^2"$HBIT&,YK<T348M2LH]KIYBC:03
MR:L7ND65_('F@1VQ@MTI))2]Y$1]V6IQ0\6:J!_K$_[YKK/#EY+J&FK<3OOD
M)P>,4?\`",:6?^78?F:O6=E%80""%`B`YIU91:LAS:.;\<_ZNV^IJ+P4/](N
M!VVBIO'7^JMOJ:A\%_\`'U<?[@JO^794?A-CQ0!_8\_'<5P/0@>XKO\`Q3_R
M!I_J*\_'WAQW%7A2X'7>"!^XN1_MBK/C,?\`$L7I]^JW@C_4W7^^*M>,_P#D
M%C_?J)?Q#/[1PY`)YQ@\5Z?IT0@M($7H(P,?A7F!'TKU"T'[F+_<7^0JL5L.
M9SGB3Q'<V5V;2U(4K]YL5SUWJ=WJTD8G8,00GIUJ;Q$?^)Q<56TI%DU&W5ON
MF05I3@E"XTO=/0M,L8["QB@C7H`6(ZY-8FO>)YK&\-K:QJ6C^\YKIPH#$#@"
MJ4^C:=/.TKVL;ENI(-<L9+FU,EN<B?%VJ==T?_?-1W'B?4;J"2%VCVN,'"UV
M'_"/Z7_SY0_E5/5M#T^'3IY([6-75>&%:QJ1[&B:.$/`&1DXVFKV@#_B=Z?_
M`-?$?_H0K/!;:I(P#6AH'_(<T_\`Z^(__0A6U7^&S8^[J***^%-#X!H;I10U
M?>F9Z5I/_(*M?^N:U<95/50?PJGH_P#R"[;_`*YK6#XPN[BUN85CD>/<O\+5
MPI7F<]KR.JV)_<'Y4H50?E4#'>O,O[4OO^?N7\ZEM-<U&UD1DN7)]":U]@RN
M0]!U)KE+1GM8T:8=`37F]U+--<R-<9\S=\VX=*])M9#<6L<[(5,B[L>E<AXS
MLT@OHYD7Y9E^;\*F@[.PH;V-[PQ_R!H?QK*\=?=M_K6IX7.=&AS@=>]97CG!
M%OC!YIP_B#^T2^";M%2:V;_6'YP*U_$.FMJ6GR1QC$B_,M<!I]W)8727$389
M3\P/I7?Z9K=IJ<:E)`DO\2,>?P]:*D&G=!.&MSSN6&2)V1U=67U%;WA/1YI[
MP73QE(H^A;^*NR>TMYFW/#&Y]2*=+)!:IEW2)%[$XHE6<ERB]H-NIA;VLLI.
M`J]^]><V=K)JVH>2G61RQ8=JU/$?B(7G^C6S?N@>?]JG>"8U;4))#_"E.*<(
MW925E<Z>PT:RTZ-%C@4G^)FZFKQ55&,`#VIEU)Y$$DH&652:\XNM7OKJ=I&G
MD`)XPV-M9PBY]2(JYZ3M7VI>$Y4[3ZUYA]ON_P#GYE_[ZH:\N7_Y;R_]]5?U
M7S*Y#T.^U:TTZW:225"W9!][\J\[O[U[^]DG<%6D.5/M43.TARS$GU-%;4Z:
M@..@Z*22%MT3,I'/RG%6QKNI(H`NIE_6NL\,VT,ND1-+!&S9/)&:U?L=H?\`
MEA#^"U$ZJ3M8)S.!&O:M(<1W,S$]L5V^B"Z%A&]V6>5AGY^,5:6UM8Q^[AB%
M0WFHVME'F>9%`'`W<UC.2FK)$MW.=\<'!MD[L":9X*_X^KG_`'16/K&JMJMZ
MT^,1K\J*>"/>MCP3Q<7/0':*V:M3U';2QL^)P3H\P`R<CBN!$4O]QQ_P&O5&
M".,,%-,\B'^XE8PK<O0(RL8'@VSDM[*228%=YRJD8-.\:.BZ9&.[/6S/<VUJ
MN995C4=R:XKQ1K":C<I'$?W,8('U]:=-.4KB6LC$P?3O7J=F/W,/^X/Y"LC0
M+&U?2(&DAA<D=2.:V55=JJ`5"]`!1B'?0)STL>>^(P1K,_%4;63R+J*4](V#
M?D:]+>RLY&+26\3-ZD5ROC*W@MW@$2(H8=`*VI5.9<HX3OH=9%*LD:21\[P&
M_.N2\0W>JV-_*4GF6%C\I'0U)X=\2)!"+.]^ZOW9/Z5U"M:W:95XY5(R.<UB
MTZ;N+9W//_[=U0?\O4GY_P#UJ9+K6HR(R27,C*PY!_\`U5Z%]DM?^><7Y52U
MFVMTTRX*11@[>P]ZN-5=AIGG>6P`QS@UHZ!_R'-/_P"OB/\`]"%9X'`XK0T#
M_D.:?_U\1_\`H0K:K\+-C[NHHHKX4T/@&AJ*4]*^],STG1_^039_]<EK.\1:
M!<:M/%)"ZC:O\5&F>(M,@L+>*6Y5&5-K<&K?_"2Z5_S]K_WR:XGSQ=TCF][F
M.=_X0F^_OQ?E3X/!5QYL9FG0*/[HKH/^$ETG_G[7_ODU$WBC2!TNMW_`35>T
MJ=A\\C6CB6.-857"HN.:X[QQ<QR74,$?WHURU:%[XSMHXV2U1I7]6KC+BXFN
M)VFD;=*S;MU70IN]Y%0AK<W=,\.WNH6B3PW@B20XQS577-)NM-$/GW`EW'''
M-;N@:UIUGID4,\P60'=C%4/%NHV>H"W^RRAC&<\"G>7/L/4YS'>E!*-N4E6'
M3VI.U%;FA:75;Y5VK=3*H]&S4<MW<7!W3.[MZ,U0[:"*+"Y0[5N^#[M(=4VO
M\OF#`K"I\<C1.KJ<,IR*F:NK$GJDB+(A5AP1BN1O/!,C2[[6<!22VUA4NG>-
M(658KZ-P>@=16HOB?2F7)NL?[RUQVJ0V(Y'$Y_\`X0F^_OQ?E1_PA-]_SUB_
M*NC/B32O^?M?^^31_P`)+I/_`#]K_P!\FM/:5.PN>9S9\$7^/]?%Q[5A.C0L
MR,064E3BN_;Q)I1!'VM>GH:X&Z*M<2E6#)O)!'O6U-R>YK"_VAJW4\8VJ[*/
M8TOVRY_Y[O\`G4>VC;6EBQ_VJX_Y[2?G2,[/]]BWUIM%`!CO3UD>,YC=E/L<
M4RB@1+]KN?\`GX?\Z3[7<?\`/P_YU'1BBPN4<TDD@^9V;ZFDVY/2DHJD42I=
M3J-H=P,]C7J%N,P1DG)*+_(5Y7QD9/0YKO[;Q-I0CB22Y52H`/RGT%<V(BV]
M#&9ROB"ZFCU>=5D8#M@UEM/++_K'+8]35[7;F&\U2::$@H_((%9U:TOA+C\(
M[MSTIRRR1\H[+]#BF4511+]KN?\`GX?\Z:US.Z[7E9A]:9MHQ0+E%[5?T#_D
M.:?_`-?$?_H0K/K0T#_D.:?_`-?$?_H0J*OPLH^[J***^%-#X!H:BAONU]Z]
MC,^A_!O[+^G>)_"^GZW-KMS`UY`LI0(/ES6I_P`,E:)_T-DWY+7IW@B.2?X+
M:?'`K-+)I05%7J3LKY*/PZ^(ID8#0M>SD_P/ZU\M0Q-:K4FG6Y;#/1_&'[+.
MHZ'I-SJ6BZLFI^6I<P-'AB/4'/6J/P\_9\L_&G@<^))=8GMI"KGRD0=5[5[Y
M\)].U;1_AA9VWB+S!=QQ2&196^9%YP#^%4?@@MO=_#>8(56TDN;H*5[*7./T
MKGEF==*2YKV=KV%RGQ*R[2?8FDKZ0TCPW\!)-4BT'SI[Z_DD\H2N\@#2=.V!
MUKF/CY\'M+^',=CJ>BNXL[N3RFAE;)C<`D$'KV->]1S2#DJ<TTWM<#Q;WHP!
M7TAX5^$_PTT?P9'K?BJ\&H7+0":6..?E,C(4*ISFKGA+P5\%?B1-/INC:;?V
MMY&A<"220,!ZC)(-1/.:49.R;2W?0#YD[4E>OQ?"6PT/XV6G@[4"]WI\V'`)
M*ET(/4CW%>D^,OAA\&_`=S:3ZXMQ;Q3@I';K([;V_O<'/%5/-Z2:BDW?:P'R
MO17T?\4/@AX3T[PS:^)/#:26\+21EHS(S++&Q'KR.M='XD^!WPOT/P[;ZSJ0
MGTV!/+>:596;=D?=P<]:AYS1LGRO5V`^3=M+7U-X5^&_P7^(T-W:^&XK@W$"
M_,^^0,F>_P`W%8=Y\/\`X-?#N^.D^+=1NK_4"=V,N/+4]!\M5_;%._+RN_:P
M'SIUHKZ.^*OP/\)6'@67Q7X46:W2&,3!"[,DJ?0\UG_"OX2^`[_PB/$?BN_6
M>5E,AMEN-NQ1[#G-"S:C[-U+/TZ@>`T;:^E?#WAWX$>,-831=,TV^BO)<B(R
M-*H8^Q)KB/B1\$O^$8\=Z7H6DS.UIJK@0-)R\1[CW`JJ6:TI2Y9)J_<#R&CB
MOJ/6/A'\)/AEIELWBY[BXN)_E5F=_G8=<!/ZTZP^#OPG^(V@7%WX1>>UDCRB
MR>:_RN/4.?Y5#S>DU?D=N_09\M45['\)/@E%XQ\0:I;ZU.ZV.E3F!UC&#(X/
M0'TKLK_1OV?M(U"72KJWNS<POY;MF8A6Z=1Q3JYM24E"*;]!'S52U[U\9/@;
MH?AGPN/%?A>646@VEX9&W`JW0J>M;5_\%_!]O\''\316#C5/L(G$HF;&X@=L
MXJEFU%J,EU=AGS90H9F`3.XG`QWKN?@MX5TSQCX^LM)UB)IK2:-V9%?!X''3
MFO2/'GP^^'G@+XE:+:7=M+:Z+/"7F`D=B9,_+WS^57B,RIPFZ23N(\<U'P'X
MFTG3FU2^T2]M[/`/G,ORX/2L.WA6>XBB<[5D=4SZ9/6ON_QZO@\^`@OB,R#0
M"L>"I;./X>G-?-GQ!@^#TFD0+X+>9M1-Q&I4F093//WN*Y<)FKJQ:E%_+]1\
MH?$#X,Z'X0\%KKEGXC6\N/W?^C@K_$.>E>/GI7TI\6?A!X8\.?#:+5=*LIH[
MYW@4.\[N/FZC!..M3:7\#/`/@[P=#K_CF>:9G56DPY549A]T!:C#9G&$+R;;
M;ML!\R]:-M?4GACP!\#_`(BK<6GAZ.>.YB7+-YLBE??YC@UY+<?"J"S^*_\`
MPAEYJ:1V8D#M=,P7]V1D=>-U=E+-*4N9--/S%8\VQB@<'./>OIKQ'X-^"'@1
M;:VU.TNM1FE4_O(978G'=MI`%27?P0^'WC?P5-K_`(,%U9NJ2-$69F#,O52&
MSW%8K.*3?O1:7>P'`_!SX'V?Q/\`#]YJ-QJ<]J;><Q"-5_V0>OXUY;X@TM-&
MUN]TY)&D6VF:(.PQG:<5]2?LFQM'X,UI&&TIJ#*PQC!"`$5Q7PY^$>F?$7QY
MXGO-:DE^RV5ZRB%#@LQ)/-<U',G"M5E.7NH+'@7I17T?KFG?`?P_K,NBWFC:
MDUQ;R>5(X,NU6'&<YKF_C!\./`&CZ`-8\(:S;^:C+OL_M(D9E;N!G(KLHYM"
M<U%Q:OUMH!XG6AH'_(<T_P#Z^(__`$(50J_H'_(<T_\`Z^(__0A7HU?A8'W=
M1117PIH?`-#?=HHQGBOO69GW;\/;M]-^#^DWJ`.\&FK*H/LE>$G]KSQ6'(&C
MZ5U(Z-_C7%67QU\::9H*>'8KVW2TBA^SB,P@G9CU^E>?$$G=WSDUX.$RB/M*
MDJZO?8.8]5\5_M'>-/$^GRZ:7LK""<,LAMD.XK]23^E>Z_`#CX*KS_#<?R-?
M&G6N]\._&?QAX1\/?V+IMS;QV(W*%:($\]:TQF5\U%4Z*2UN!A^`\GQSHW7_
M`(_D_P#0A7TI^UC"D_ACP]%(<))J*JQ]`4-?*NFZA=:7J-O?VDFV>"02(2/X
MNU=5XT^*_BCQYIUO9Z]=QS06TOFIMC"G.".WM3Q6!G4JTYQV6X7/JC5+:#X:
M?#Z&\\*>&(M7N%BC7R88\M*#C+'`)/K69\*?&6M^*_$$K:OX"_L1XXB4O#`8
M^_*Y(KY^\/?'SQUX7TV&SM=32>VB7:BW,08JOH".?SJTW[2?Q$FNXY%U*W0X
M^6)8!M;ZUYTLHKZQLG?K<.8]2\5_\G2Z-_U[1_\`LU87[8`QK/A_''[I_P"8
MKRJ\^*?B:_\`%T7BVYN(VU.U01+(L8"CKCY>_6JGCGXBZ]X^GM9?$$\4TEN"
ML16,+@'Z5U87+:M.M";M9;AS$=GXLU^]GL].N]:OYK+S440M,2F`>!C.*^G?
MVCQ_Q9F/G^*#^E?(4,K6\\<\9P\9##ZBNU\3_&'Q9XST'^P]3NK>:S!4D+"%
M/R].:[,7E\IUJ<Z=K)W8KGIG['O_`"'=<_Z]T_\`0JXC]HD_\79U/O\`+'_*
MN:\$?$+7?`$US<>'[A(I+E`KEHPW0^]9OB?Q-J7BK6IM5U257O)2`[*@7/Y5
M,,)4^MRK=&K#YCZV\3D#]G9LG@Z:G\J/A_H&F^$/A/:ZOHFBIJ>H-:"9D5<R
M3N>V?Z5\WWOQJ\67/A@^&9[N#^SS"(#&(1NV_6CPA\9O&/@JQ33M+U,M;#YD
MBF0.!]">17G/*Z[A))];^H7/??`OCWQ'XK\6V=OK'PX.GPY)6\:W93;D#KDK
MC\J=\7[^*R^+'@>:9@D8E9<GU/%>,3?M)_$.XD1TU*"%5[)`O/YURGC3XE^(
M_'5Y:3ZY=H\MF287C380?PJZ645_:*4DDO4.8^@_VHO!^N^)X=&N=%TVXOD@
M+B18$WLN>^*X[X7?L_ZYK&C7-YJ^HZEX=97)2+;M)'J0>E<EHG[1/C_1(19I
MJ<=TJ(%1;B(,0/J,'\\TS7/VAO'^LV4EI+J45M%(I5O(B`)_&M*>#QE.#H1:
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M=SZM^+&DWWB#X,I:Z7:RWEP\,#+%$,LP`["O';WX`1>'?`UOXIU'4YX+Y?+=
MK-XL!7+#Y>><UR^@?'[QSX5T^+3K74(Y8(0%07,>\J/KZ5G>+_BYXP\9PHFK
MZB#;1R!EAAC"IN'()[G\:PHX#&4FX0:LW<.8^E_CA,D'PGT^60@(D]HSGT`/
M--^.&AZAXM^$MO#H5M)>S;X)A'#R64#J!WZU\V>)?C)XK\6Z`=!U6YMY;'Y2
M56$`_+P.:L>%?C;XZ\)6*V&GZF9;6%<B&=%<(/8GFLX91B(I3C:Z=PYC?^%G
MP-\2Z_J-R-275?#L4:#;+Y1C,A]/>MWP/\.=)M_CO+X?U._;6X[*V,VZXYWR
M<<$9.<9_2N6O?VE?B'?Q-$M_;6P88S'$,_G7`VGB?6+#7AK=M?W":F'+^>6R
MV>_/<>U=7U/&57+VC2]`N?6?Q-\<:[X-U*+2]"\`?VI:%`3,L!=,^F`*ZCP1
M>W&I>`7O+KP__8$\R3,]GLV[3S\V,=^M?,]M^TQ\0A$(A>6LC8QO,`R*JC]I
M#XA?9Y89-4BE1]P;=`O&>PKB>3XBRC97[W"Y[1^RISX4\0_]A-__`$$5S?P>
MA\3KXZ\7W'AZXTUH1?,MQ;W>X'[QPRX_&O)O!/Q@\4>`;"XM=(DMD@N9S-(9
M8@27(YZ>U9FB?$#Q)X=\17>M:5?O;7MRY:?8!L?//*GBMUE==\^WO!S'T?KO
MQ5\2Z;K%SI]U\+)]2,3[!<1(S+*/[P.P_P`^].^-'@WP_J_PPGU^?18-)U)(
MHYE8(%>,DC*-C&>N*\C'[4'Q"11NN+#ZO!S^E<KXS^*GB_QU:"#6M3>2T!W>
M3&H1"?<#K^-*CE6(52,K)6ZW8<QQF3M!`.6Y/I6AH'_(<T__`*^(_P#T(50Q
=Q5_0?^0YI_\`U\1_^A"OH:OP,#[NHHHKX4T/_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
